WCG has appointed healthcare industry veteran Sam Srivastava to take the helm as its new chief executive officer, overseeing all global operations.

Srivastava, who takes the reins from retiring CEO Donald Deieso, brings more than three decades of healthcare industry experience to the table, with previous leadership positions at value-based care delivery company NeueHealth, Bright Health, Magellan Healthcare, Cigna and United Health Group.

“The clinical trials industry is in need of disruption,” Srivastava said in a statement announcing his appointment, “and WCG is the only company in the market with the solutions, data, technology, and expertise to make it happen. We are in a unique position to drive the advancement needed throughout the clinical trials ecosystem to enable the delivery of better healthcare,” he said.